New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery LONDON — Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus […]
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Cambridge / Edinburgh, UK: Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 […]
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh The funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding validation Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins […]
HOLLYWOOD, Fla. — StarLIMS, a global enterprise informatics platform for laboratories, today announced a strategic investment by Turn/River Capital, a leading software private equity firm. Existing investor Francisco Partners will exit its investment as a result of this transaction. StarLIMS powers manufacturing and research lab operations worldwide. The company enables greater data automation and visibility, […]
Additional funding of $20 million accelerates commercialization of Trailhead’s iPSC-derived human cell and media products. BEACHWOOD, Ohio and CAMBRIDGE, Mass. — Trailhead Biosystems Inc. (www.trailbio.com), a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding extension was led by […]
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors Fremont, Calif. – Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed […]
London – M&G Investments (M&G) today announces that it is leading a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming technology. The investment of patient capital into a fast-growing private UK company, spun out from the University of Cambridge, marks a major vote of confidence in […]
Abbelight Announces Successful Series B Investment led by AVANT BIO to accelerate imaging innovation and scale adoption across a broader customer base. Paris, France – January 8, 2026 – Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth […]
Waltham, Mass. – Vizgen, Inc., a leader in spatial multi-omics, today announced the closing of a $48 million financing. The financing was led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures with participation from the company’s existing investors. Proceeds from the round will be used to execute on Vizgen’s innovation roadmap, expand […]
MIT spin-off and winner of the Global Photonics Engineering Contest, relocating R&D facilities to the Netherlands to scale photonic sensing for chemical monitoring Eindhoven, the Netherlands: Perceptra, the MIT spin-off pioneering photonic chip-based AI-enabled Raman sensors for chemical monitoring, has announced it has secured a €1.2 million investment from PhotonDelta, the Dutch photonic chip industry […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
